{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:08:56Z","timestamp":1760144936044,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cjca.2023.06.016","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T20:44:12Z","timestamp":1687293852000},"page":"1446-1448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linking Plasma LTBP-2 Levels and Clinical Outcomes in Patients With Dilated Cardiomyopathy"],"prefix":"10.1016","volume":"39","author":[{"given":"Anran","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zamaneh","family":"Kassiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9154-9028","authenticated-orcid":false,"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2023.06.016_bib1","first-page":"547","article-title":"Cardiomyopathies and genetic testing in heart failure: role in defining phenotype-targeted approaches and management","volume":"37","author":"Yogasundaram","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.06.016_bib2","doi-asserted-by":"crossref","first-page":"eabo1984","DOI":"10.1126\/science.abo1984","article-title":"Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies","volume":"377","author":"Reichart","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cjca.2023.06.016_bib3","first-page":"1436","article-title":"Prognostic role of circulating LTBP-2 in patients with dilated cardiomyopathy: a novel biomarker reflecting extracellular matrix LTBP-2 accumulation","volume":"39","author":"Nishiura","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.06.016_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/j.2040-4603.2015.tb00624.x","article-title":"Extracellular matrix communication and turnover in cardiac physiology and pathology","volume":"5","author":"Takawale","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.cjca.2023.06.016_bib5","article-title":"Disparate remodeling of the extracellular matrix and proteoglycans in failing pediatric versus adult hearts","volume":"7","author":"Jana","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2023.06.016_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2015.05.005","article-title":"Latent TGF-beta-binding proteins","volume":"47","author":"Robertson","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.cjca.2023.06.016_bib7","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1091\/mbc.11.8.2691","article-title":"Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta","volume":"11","author":"Saharinen","year":"2000","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.cjca.2023.06.016_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.matbio.2006.12.006","article-title":"LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein","volume":"26","author":"Hirani","year":"2007","journal-title":"Matrix Biol"},{"key":"10.1016\/j.cjca.2023.06.016_bib9","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1128\/MCB.20.13.4879-4887.2000","article-title":"Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement early in mouse development","volume":"20","author":"Shipley","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cjca.2023.06.016_bib10","doi-asserted-by":"crossref","first-page":"e13377","DOI":"10.1111\/apha.13377","article-title":"LTBP2 knockdown by siRNA reverses myocardial oxidative stress injury, fibrosis and remodelling during dilated cardiomyopathy","volume":"228","author":"Pang","year":"2020","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.cjca.2023.06.016_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ajhg.2009.03.017","article-title":"Null mutations in LTBP2 cause primary congenital glaucoma","volume":"84","author":"Ali","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cjca.2023.06.016_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ejhg.2010.11","article-title":"LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary glaucoma","volume":"18","author":"Desir","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cjca.2023.06.016_bib13","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1128\/MCB.15.12.6932","article-title":"Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils","volume":"15","author":"Gibson","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cjca.2023.06.016_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/CS20120058","article-title":"The novel marker LTBP2 predicts all-cause and pulmonary death in patients with acute dyspnoea","volume":"123","author":"Breidthardt","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cjca.2023.06.016_bib15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s44161-022-00113-w","article-title":"Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension","volume":"1","author":"Boucherat","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.cjca.2023.06.016_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/1354750X.2012.677860","article-title":"LTBP-2 acts as a novel marker in human heart failure: a preliminary study","volume":"17","author":"Bai","year":"2012","journal-title":"Biomarkers"},{"key":"10.1016\/j.cjca.2023.06.016_bib17","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23005251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23005251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:52:23Z","timestamp":1760107943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X23005251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0828282X23005251"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2023.06.016","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linking Plasma LTBP-2 Levels and Clinical Outcomes in Patients With Dilated Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.05.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}